Heritage Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 19-12-2024
- Paid Up Capital ₹ 0.10 M
as on 19-12-2024
- Company Age 16 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.50 M
as on 19-12-2024
- Revenue 46.13%
(FY 2022)
- Profit 125.72%
(FY 2022)
- Ebitda 34.73%
(FY 2022)
- Net Worth 17.78%
(FY 2022)
- Total Assets 38.12%
(FY 2022)
About Heritage Biotech
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.50 M.
Kapil Aggarwal, Rakesh Aggarwal, Shweta Aggarwal, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232DL2008PTC183675
- Company No.
183675
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Sep 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Heritage Biotech Private Limited. offer?
Heritage Biotech Private Limited. offers a wide range of products and services, including Fertilizers and Soil Additives, Potassic Fertilizers, Bleaching Powder, DCM Shriram Bleaching Powder, Ammonium Compound, Ammonium Chloride, Metal & Metal Made Products, Nano Powder, White Pigments, Zinc Oxide Powder.
Who are the key members and board of directors at Heritage Biotech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kapil Aggarwal  | Director | 24-Sep-2008 | Current |
| Rakesh Aggarwal | Director | 24-Sep-2008 | Current |
| Shweta Aggarwal | Director | 26-Mar-2015 | Current |
| Poonam Aggarwal | Director | 26-Mar-2015 | Current |
Financial Performance of Heritage Biotech.
Heritage Biotech Private Limited., for the financial year ended 2022, experienced significant growth in revenue, with a 46.13% increase. The company also saw a substantial improvement in profitability, with a 125.72% increase in profit. The company's net worth Soared by an impressive increase of 17.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Heritage Biotech?
In 2022, Heritage Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 27 Jul 2012 | ₹2.50 M | Open |
How Many Employees Work at Heritage Biotech?
Unlock and access historical data on people associated with Heritage Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Heritage Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Heritage Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
